NCT00617799 2023-10-10Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic MelanomaUniversity of NebraskaCompleted15 enrolled
NCT01288963 2023-06-15IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced MelanomaBeth Israel Deaconess Medical CenterCompleted153 enrolled